Screener
Capricor Therapeutics CAPR Net Income
Net Income at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Capricor Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Capricor Therapeutics’s 10-Q, filed May 13, 2026.
- Filed
- May 13, 2026, 5:20 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-060382
| REVENUE / TOTAL REVENUE | Three Months Ended March 31, 2026 / — | Three Months Ended March 31, 2025 / — |
|---|---|---|
| TOTAL OTHER INCOME (EXPENSE) | 2,831,508 | 591,354 |
| LOSS BEFORE INCOME TAXES | (33,941,345) | (24,391,594) |
| (Provision for) benefit from income taxes | — | — |
| NET LOSS | $(33,941,345) | $(24,391,594) |
| OTHER COMPREHENSIVE INCOME (LOSS) | ||
| Net unrealized gain (loss) on marketable securities | (536,881) | 784,972 |
| COMPREHENSIVE LOSS | $(34,478,226) | $(23,606,622) |
| Net loss per share, basic and diluted | $(0.59) | $(0.53) |
Item 1. Financial Statements.
FAQ
- What is Capricor Therapeutics's net income?
- Capricor Therapeutics (CAPR) reported net income of -$33.94M in Q1 2026.
- How has Capricor Therapeutics's net income changed year-over-year?
- Capricor Therapeutics's net income decreased by 39.2% year-over-year, from -$24.39M to -$33.94M.
- What is the long-term trend for Capricor Therapeutics's net income?
- Over 4 years (2021 to 2025), Capricor Therapeutics's net income has grown at a 51.3% compound annual growth rate (CAGR), from -$20.02M to -$105.04M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Capricor Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude